| Lipids Management |
0 |
0.9 |
| Thyroid Disease |
0 |
0.91 |
| Thyroid Associated Eye Disease |
0 |
1 |
| Statins |
0 |
0.99 |
| Glucocorticoid |
0 |
0.98 |
| Orbit |
0 |
0.39 |
| Thyroid |
0 |
0.35 |
| Cardiovascular Risk Management |
0 |
0.32 |
| LDL Cholesterol |
0 |
0.97 |
| Endocrinology |
0 |
0.12 |
| Generics |
0 |
0.12 |
| Intravenous |
0 |
0.12 |
| Steroids |
0 |
0.12 |
| High Density Lipoprotein (HDL) cholesterol |
0 |
0.09 |
| Care and Maintenance of Vision |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Biologic Therapy |
0 |
0.05 |
| Health Care Reform |
0 |
0.05 |
| Social Determinants of Health |
0 |
0.05 |
| Board Certification |
0 |
0.04 |
| Diplopia |
0 |
0.04 |
| Exophthalmos |
0 |
0.04 |
| Geriatrics |
0 |
0.04 |
| Health Care Quality, Access, and Evaluation |
0 |
0.04 |
| Hospital |
0 |
0.04 |
| Hypercholesterolemia |
0 |
0.04 |
| Lipoproteins |
0 |
0.04 |
| Metabolism |
0 |
0.04 |
| Minnesota |
0 |
0.04 |
| Nutrition |
0 |
0.04 |
| Outpatient Clinic |
0 |
0.04 |
| Quality of Life |
0 |
0.04 |
| Surgery |
0 |
0.04 |
| Targeted Cancer Therapy |
0 |
0.04 |
| Visual Acuity |
0 |
0.04 |